- Home
- CNTX vs DTF Comparison
CNTX vs DTF Comparison
Compare CNTX & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- DTF
- Stock Information
- Founded
- CNTX 2015
- DTF 1991
- Country
- CNTX United States
- DTF United States
- Employees
- CNTX N/A
- DTF N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- DTF Investment Managers
- Sector
- CNTX Health Care
- DTF Finance
- Exchange
- CNTX Nasdaq
- DTF Nasdaq
- Market Cap
- CNTX 78.0M
- DTF 78.2M
- IPO Year
- CNTX 2021
- DTF N/A
- Fundamental
- Price
- CNTX $0.65
- DTF $11.22
- Analyst Decision
- CNTX Strong Buy
- DTF
- Analyst Count
- CNTX 5
- DTF 0
- Target Price
- CNTX $5.50
- DTF N/A
- AVG Volume (30 Days)
- CNTX 330.3K
- DTF 21.1K
- Earning Date
- CNTX 08-06-2025
- DTF 01-01-0001
- Dividend Yield
- CNTX N/A
- DTF 3.64%
- EPS Growth
- CNTX N/A
- DTF N/A
- EPS
- CNTX N/A
- DTF 0.44
- Revenue
- CNTX N/A
- DTF N/A
- Revenue This Year
- CNTX N/A
- DTF N/A
- Revenue Next Year
- CNTX N/A
- DTF N/A
- P/E Ratio
- CNTX N/A
- DTF $24.34
- Revenue Growth
- CNTX N/A
- DTF N/A
- 52 Week Low
- CNTX $0.49
- DTF $10.29
- 52 Week High
- CNTX $2.75
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- CNTX 51.44
- DTF 55.44
- Support Level
- CNTX $0.62
- DTF $11.16
- Resistance Level
- CNTX $0.70
- DTF $11.25
- Average True Range (ATR)
- CNTX 0.04
- DTF 0.04
- MACD
- CNTX 0.01
- DTF 0.00
- Stochastic Oscillator
- CNTX 67.29
- DTF 71.43
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.